Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Semaglutide is a highly selective GLP-1 agonist
Since the start of 2026, more than 500 new lawsuits involving drugs like Ozempic have been filed in federal court
Wegovy is approved for chronic weight management (2021), cardiovascular risk reduction in adults with obesity and CVD (2024), and non-cirrhotic MASH with F2-F3 fibrosis (August 2025)
Common side effects include mild swelling, bruising, discomfort, and temporary redness at the treated area, which typically resolve within a few days
Patient Information leaflet Click here for the Patient Information leaflet Please read before using the product You may also like Select at least 2 products to compare
US$ 26.52
US$ 27.57
US$ 28.69
US$ 25.33
